J1452 – Injection, fomivirsen sodium, intraocular, 1.65 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1452
- Long description
- Injection, fomivirsen sodium, intraocular, 1.65 mg
- Short description
- Intraocular fomivirsen na
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 2001
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J1452?
J1452 is a HCPCS Level II code for injection, fomivirsen sodium, intraocular, 1.65 mg. It was discontinued on December 31, 2025.
Does Medicare cover J1452?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1444 – Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
- J1445 – Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
- J1446 – Injection, tbo-filgrastim, 5 micrograms
- J1447 – Injection, tbo-filgrastim, 1 microgram
- J1448 – Injection, trilaciclib, 1mg
- J1449 – Injection, eflapegrastim-xnst, 0.1 mg
- J1450 – Injection fluconazole, 200 mg
- J1451 – Injection, fomepizole, 15 mg
- J1453 – Injection, fosaprepitant, 1 mg
- J1454 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455 – Injection, foscarnet sodium, per 1000 mg
- J1456 – Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457 – Injection, gallium nitrate, 1 mg
- J1458 – Injection, galsulfase, 1 mg
- J1459 – Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460 – Injection, gamma globulin, intramuscular, 1 cc
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.